Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | masitinib | GDSC1000 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | selumetinib:piperlongumine (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | PF-4708671 | GDSC1000 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | etoposide | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | GW 441756 | GDSC1000 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | foretinib | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | CAY10576 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.7 |
mRNA | Salubrinal | GDSC1000 | pan-cancer | AAC | -0.023 | 0.7 |
mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |